Vietnam Investment Review on MSN
Celosia Therapeutics begins phase 1b trial for ALS therapy
SYDNEY, March 24, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing of the first ...
Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing of the first participant in its Phase ...
("Olatec"), developing one of the most clinically advanced specific oral NLRP3 inhibitors, dapansutrile, today announced that two patients have been randomized in a 12-month clinical trial, named DAPA ...
South Florida remains the absolute core of the maritime lifestyle. Setting up a brick-and-mortar operation here ...
In Melbourne, McLaren was 0.85 seconds per lap off the pace of the Mercedes works team, and team boss Andrea Stella ...
Morning Overview on MSN
GM to phase out CVTs, starting with the FWD Chevy Equinox
General Motors appears to be moving away from continuously variable transmissions (CVTs) in its compact SUVs, starting with ...
The Rhenus Group has integrated a fuel cell truck from Daimler Truck on a trial basis. With this deployment, Rhenus, together ...
A market-wide review of new models in showrooms found that only 23% have a gear stick, which is rapidly dying out as car ...
Back in 2022, the Kia EV6 made a big splash as a cool, edgy EV with a focus on driver engagement. It won a bunch of awards ...
Detailed price information for Serina Therapeutics Inc (SER-A) from The Globe and Mail including charting and trades.
HUZHOU CITY, ZHEJIANG PROVINCE, CHINA, March 24, 2026 /EINPresswire.com/ -- The global passenger elevator industry is ...
Early results show major gains in tracking waste, reducing disposal, cutting costs and improving efficiency at Ford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results